The molecular pharmacology of doxorubicin in vivo

Eur J Cancer. 1991;27(5):532-5. doi: 10.1016/0277-5379(91)90209-v.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Binding Sites
  • Cell Membrane / metabolism
  • DNA Topoisomerases, Type II / metabolism
  • DNA, Neoplasm / metabolism
  • Doxorubicin / pharmacology*
  • Doxorubicin / therapeutic use
  • Enzymes / metabolism
  • Free Radicals
  • Humans
  • Neoplasms / enzymology

Substances

  • DNA, Neoplasm
  • Enzymes
  • Free Radicals
  • Doxorubicin
  • DNA Topoisomerases, Type II